98 related articles for article (PubMed ID: 2258360)
1. Combined utility of gene rearrangement analysis and flow cytometry in the diagnosis of lymphoproliferative disease in the bone marrow.
Sandhaus LM; Voelkerding KV; Dougherty J; Raska K
Hematol Pathol; 1990; 4(3):135-48. PubMed ID: 2258360
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
Sadek I; Greer W; Foyle A
Clin Invest Med; 2000 Dec; 23(6):366-75. PubMed ID: 11152404
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
5. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
Brink DS; Grosso LE; Dunphy CH
Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
[TBL] [Abstract][Full Text] [Related]
6. Follicular pattern of bone marrow involvement by follicular lymphoma.
Torlakovic E; Torlakovic G; Brunning RD
Am J Clin Pathol; 2002 Nov; 118(5):780-6. PubMed ID: 12428800
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry in the bone marrow staging of mature B-cell neoplasms.
Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G
Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663
[TBL] [Abstract][Full Text] [Related]
8. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
9. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas.
Brinckmann R; Kaufmann O; Reinartz B; Dietel M
J Pathol; 2000 Jan; 190(1):55-60. PubMed ID: 10640992
[TBL] [Abstract][Full Text] [Related]
10. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis.
Bregni M; Borrello MG; Siena S; Orazi A; Biassoni D; Bonadonna G; Gianni AM
Haematologica; 1989; 74(4):397-400. PubMed ID: 2507414
[TBL] [Abstract][Full Text] [Related]
12. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations.
Knowles DM
Semin Oncol; 1993 Dec; 20(6):583-610. PubMed ID: 8296197
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies.
Fakan F; Skálová A; Kuntscherová J
Gen Diagn Pathol; 1996 May; 141(5-6):359-63. PubMed ID: 8780936
[TBL] [Abstract][Full Text] [Related]
18. Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates.
Evans MG; Brynes RK; Crymes A; Reid J; Haghighi N; Botros C; Zhao X; Rezk SA
Hum Pathol; 2022 Dec; 130():58-64. PubMed ID: 36252861
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional reconstruction of non-Hodgkin's lymphoma in bone marrow trephines.
Salisbury JR; Deverell MH; Seaton JM; Cookson MJ
J Pathol; 1997 Apr; 181(4):451-4. PubMed ID: 9196445
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma.
Kang YH; Park CJ; Seo EJ; Huh J; Kim SB; Kang YK; Chi HS
Cancer; 2002 Jun; 94(12):3073-82. PubMed ID: 12115337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
